August 26, 2015

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

August 26, 2015

The National Association of Chain Drug Stores has announced the winners of its Total Store Expo Product Showcase. 

August 14, 2015

Mylan announced will continue to urge its shareholders to vote in favor of its proposed acquisition of Perrigo despite Institutional Shareholder Services’ recommendation against the deal in a recent report.

August 11, 2015

Three years after it launched its EpiPen4ASchools program, Mylan announced this week that it would continue through the 2015-2016 school year.

August 10, 2015

The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.

August 6, 2015

Mylan on Wednesday announced the U.S. launch of its generic version of Nexium (esomeprazole magnesium delayed-release capsules) in 20- and 40-mg dosage strengths.

July 29, 2015

Mylan on Wednesday announced that it received unconditional clearance from the European Commission under the European Union Merger Regulation for its acquisition of Perrigo Co., an Irish international manufacturer of private-label over-the-counter pharmaceuticals.

July 27, 2015

In a move that will reshape the generic pharmaceuticals landscape, Teva announced Monday that it would be acquiring Allergan Generics for $40.5 billion. 

July 24, 2015

On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.

July 15, 2015

A collection of eight consumer groups have written to Federal Trade Commission chair Edith Ramirez in opposition of the ongoing potential merger between pharmaceutical companies Teva and Mylan. 

July 14, 2015

Both Mylan and Dr. Reddy’s Laboratories have announced the launch of their generic version of dementia drug Namenda.

July 9, 2015

 Mylan announced Thursday that it had launched its generic version of Valeant’s Targretin (bexarotene) 75-mg capsules.

June 19, 2015

The move gives Teva standing in Dutch court, should they decide to pursue action against Mylan.

June 16, 2015

Mylan’s largest shareholder has promised to back the company’s bid to buy Perrigo, which would help fend off Teva’s $40 billion takeover offer.

June 3, 2015

Mylan announced on Tuesday that it had launched its generic version of Teva’s  Seasonique birth control.

May 26, 2015

Acquisition target Perrigo recently filed a complaint to Irish Takeover Panel regarding Mylan proposal. 

May 20, 2015

Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.

April 24, 2015

Mylan has announced that it will commence with a formal offer to acquire generic drug maker Perrigo.

April 22, 2015

Perrigo on Tuesday rejected a proposed acquisition by Mylan. 

April 22, 2015

Following Perrigo's rejection of a Mylan offer, Teva moves forward with its proposed acquistion of Mylan. 

April 21, 2015

Teva Pharmaceutical on Tuesday made a move for Mylan in a $40 billion deal barring Mylan's proposed acquisition of Perrigo. 

April 8, 2015

Mylan on Wednesday announced a proposal to acquire Perrigo in $29 billion deal. 

April 7, 2015

Mylan on Tuesday announced the launch of norethindrone and ethinyl estradiol tablets (chewable) 0.8 mg/0.025 mg and ferrous fumarate tablets, 75 mg (chewable).

March 11, 2015

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.